These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10256696)

  • 1. The latest word from the FDA: an exclusive interview with the commissioner. Interview by John A. Owen Jr.
    Hayes AH
    Hosp Formul; 1982 Aug; 17(8):1063-8, 1075. PubMed ID: 10256696
    [No Abstract]   [Full Text] [Related]  

  • 2. Janet Woodcock discusses the FDA and the drug development process. Interview by Christopher Watson.
    Woodcock J
    Drug Discov Today; 2004 Jul; 9(13):548-50. PubMed ID: 15203087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription for change: an interview with FDA Commissioner Dr. David Kessler.
    Kessler D
    Physician Assist; 1992 Jul; 16(7):61-2, 65, 68-70. PubMed ID: 10120389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demystifying the FDA: Commissioner Young punches some holes in the "black box'. Interview by Don L. Gibbons.
    Young FE
    Med World News; 1985 May; 26(9):78-9, 83-4, 89-90 passim. PubMed ID: 10271160
    [No Abstract]   [Full Text] [Related]  

  • 5. An interview with FDA Commissioner Frank Young. Interview by Carmella Bocchino.
    Young FE
    Nurs Econ; 1989; 7(5):242-8. PubMed ID: 2812067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fresh--and friendlier--wind blows from the FDA. Interview by John H. Lavin.
    Hayes AH
    Med Econ; 1982 Aug; 59(16):47-8, 52, 56. PubMed ID: 10256348
    [No Abstract]   [Full Text] [Related]  

  • 7. Advisory committee; Pediatric Advisory Committee; establishment. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(147):46098-9. PubMed ID: 15287133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advisory committee; Risk Communication Advisory Committee; establishment. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jul; 72(144):41221-2. PubMed ID: 17674496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mission: promoting, protecting the public health. FDA Commissioner Mark B. McClellan. Interview by Ray Formanek Jr.
    McClellan MB
    FDA Consum; 2003; 37(2):12-7. PubMed ID: 12715764
    [No Abstract]   [Full Text] [Related]  

  • 10. Remarks by the Commissioner. FDA.
    Kessler DA
    J Parenter Sci Technol; 1991; 45(3):118-21. PubMed ID: 1886036
    [No Abstract]   [Full Text] [Related]  

  • 11. A message to the new FDA Commissioner.
    Hatch OG
    Food Drug Law J; 1999; 54(1):5-11. PubMed ID: 11757555
    [No Abstract]   [Full Text] [Related]  

  • 12. Newsmaker interview. Margaret Hamburg aims to strengthen FDA science. Interview by Robert Koenig.
    Hamburg M
    Science; 2009 Aug; 325(5942):802. PubMed ID: 19679780
    [No Abstract]   [Full Text] [Related]  

  • 13. New FDA Commissioner sees challenges, opportunities.
    Lewis C
    FDA Consum; 2003; 37(1):9. PubMed ID: 12625298
    [No Abstract]   [Full Text] [Related]  

  • 14. Delegations of authority to the Commissioner of Food and Drugs--FDA. Final rule.
    Fed Regist; 1993 Apr; 58(61):17094-5. PubMed ID: 10125230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA commissioner discusses issues of concern to hospital pharmacists. Interview by William A. Zellmer.
    Goyan JE
    Am J Hosp Pharm; 1980 May; 37(5):738-40 contd. PubMed ID: 7386484
    [No Abstract]   [Full Text] [Related]  

  • 16. The process of drug decision making: perspectives of an FDA Commissioner.
    Hayes AH
    Hosp Formul; 1985 Aug; 20(8):896-900. PubMed ID: 10272396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Many issues in store for new FDA commissioner.
    Wadman M
    Nat Rev Drug Discov; 2005 Nov; 4(11):871-2. PubMed ID: 16299912
    [No Abstract]   [Full Text] [Related]  

  • 18. Remarks of the acting FDA commissioner: FDLI's 47th annual conference.
    Crawford LM
    Food Drug Law J; 2004; 59(2):201-8. PubMed ID: 15318391
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Good news.
    Am Fam Physician; 1974 Nov; 10(5):71, 73. PubMed ID: 4423090
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on the AVMA drug Availability Committee Statement to FDA Commissioner Kennedy.
    Crawford LM
    J Am Vet Med Assoc; 1979 Apr; 174(8):854-6. PubMed ID: 500428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.